Parexel Executive and Leadership Team

Robert Goodwin, the Chief Operating Officer at Parexel, directs the execution of complex clinical research programs across global markets. Overseeing the integration of clinical supply chains and drug logistics, the Chief Operating Officer ensures that trial management remains efficient and compliant with international regulatory standards. Goodwin manages the operational infrastructure supporting biopharmaceutical clients, focusing on the seamless delivery of data management and biostatistical analysis. By optimizing internal processes, the Chief Operating Officer drives productivity within the Clinical Research Services segment. Robert Goodwin maintains rigorous oversight of trial timelines, ensuring that site services and patient recruitment efforts align with the broader corporate mission of accelerating drug development. Through this leadership, the Chief Operating Officer secures the operational stability required to support large-scale, multi-phase clinical trials for biotechnology and medical device partners worldwide.

Andrew Smith, the President, Medical Marketing Services at Parexel, directs the strategic communication and commercialization initiatives for biopharmaceutical products. Overseeing the development of targeted medical communications, the President, Medical Marketing Services ensures that complex scientific data reaches key stakeholders effectively. Smith manages the alignment of product pricing and reimbursement strategies with market access requirements, facilitating successful product launches in competitive landscapes. The President, Medical Marketing Services coordinates with consulting teams to address client challenges related to market development and strategic compliance. Andrew Smith drives the expansion of medical marketing capabilities, ensuring that the company provides comprehensive support for the entire product lifecycle. By leveraging deep industry expertise, the President, Medical Marketing Services enhances the market positioning of client products, ensuring that therapeutic innovations achieve maximum reach and commercial success within the global healthcare ecosystem.

Amy Kissam-Sands, the President, Operational Excellence, Delivery & Innovation at Parexel, architects the framework for continuous improvement and technological advancement across all service segments. Overseeing the implementation of innovative delivery models, the President, Operational Excellence, Delivery & Innovation ensures that clinical trial management systems remain at the forefront of industry standards. Kissam-Sands drives the adoption of advanced technology products, including electronic data capture and patient-reported outcome applications, to streamline research workflows. The President, Operational Excellence, Delivery & Innovation collaborates with cross-functional teams to enhance service quality and operational efficiency. Amy Kissam-Sands leads initiatives that integrate digital solutions into traditional clinical research, fostering a culture of innovation that accelerates project timelines. By optimizing delivery processes, the President, Operational Excellence, Delivery & Innovation ensures that the company maintains a competitive edge in providing high-quality, technology-driven solutions to the global biopharmaceutical industry.

James Anthony, the Chief Commercial Officer & President, Parexel Biotech at Parexel, directs the commercial strategy and client engagement efforts specifically tailored for the biotechnology sector. Overseeing the development of specialized service offerings, the Chief Commercial Officer & President, Parexel Biotech ensures that smaller, high-growth firms receive the necessary support for clinical development and commercialization. Anthony manages the relationships with key biotech partners, providing strategic advice on regulatory affairs and product development. The Chief Commercial Officer & President, Parexel Biotech drives the expansion of the company's footprint within the biotech market, ensuring that service delivery aligns with the unique requirements of these agile organizations. James Anthony leads the commercial team in identifying and capturing new business opportunities, fostering long-term partnerships that accelerate the path from discovery to market. By focusing on the specific needs of biotech clients, the Chief Commercial Officer & President, Parexel Biotech enhances the company's overall market impact.

Debra Tatton, the Global President, Clinical & Data Operations at Parexel, directs the large-scale execution of clinical trials and data management services on a global level. Overseeing the performance of clinical operations teams, the Global President, Clinical & Data Operations ensures that trial sites are managed effectively and that data integrity is maintained throughout the research process. Tatton manages the implementation of standardized procedures for biostatistical analysis and clinical data collection, driving consistency across all regions. The Global President, Clinical & Data Operations collaborates with technology teams to integrate advanced data solutions into clinical workflows. Debra Tatton leads the effort to optimize operational performance, ensuring that the company delivers high-quality results for complex, multi-center trials. By focusing on operational excellence and data accuracy, the Global President, Clinical & Data Operations supports the company's mission to provide reliable, evidence-based research services to the global biopharmaceutical industry.

Charlotte Moser, the Chief Medical Officer at Parexel, architects the medical strategy and scientific oversight for global clinical development programs. Leading the medical affairs and pharmacovigilance teams, the Chief Medical Officer ensures that patient safety remains the primary focus throughout the entire drug development lifecycle. Moser provides critical guidance on epidemiology and health outcomes research, translating complex clinical data into actionable insights for pharmaceutical clients. The Chief Medical Officer collaborates with regulatory bodies to navigate the intricacies of product registration and post-marketing surveillance. Charlotte Moser drives the scientific integrity of clinical trials, ensuring that medical protocols meet the highest standards of efficacy and compliance. By bridging the gap between clinical research and commercialization, the Chief Medical Officer supports the successful launch of innovative therapies, ultimately enhancing the therapeutic impact of the company's diverse portfolio.

Michael Crowley, the Chief Administrative Officer, General Counsel & Secretary at Parexel, directs the legal, administrative, and corporate governance functions of the organization. Overseeing the management of legal risks and regulatory compliance, the Chief Administrative Officer, General Counsel & Secretary ensures that all business operations adhere to international laws and ethical standards. Crowley manages the corporate secretarial duties, providing essential support to the Board of Directors and executive leadership. The Chief Administrative Officer, General Counsel & Secretary drives the development of internal policies that promote transparency and operational integrity. Michael Crowley leads the administrative teams in supporting the company's global infrastructure, ensuring that corporate functions remain robust and efficient. By providing expert legal counsel and administrative oversight, the Chief Administrative Officer, General Counsel & Secretary protects the company's interests and supports the successful execution of its strategic objectives across all business segments.

Peyton Howell, the Chief Operating & Growth Officer at Parexel, directs the overarching business strategy and expansion efforts across international markets. Overseeing the alignment of operational capabilities with long-term growth objectives, the Chief Operating & Growth Officer ensures that the company scales effectively to meet the evolving needs of the biotechnology and medical device sectors. Howell manages the integration of consulting services and commercialization strategies to drive revenue and market share. The Chief Operating & Growth Officer collaborates with executive leadership to identify new opportunities for service expansion and strategic partnerships. Peyton Howell drives the execution of growth initiatives, ensuring that the company maintains its position as a leader in biopharmaceutical outsourcing. By focusing on sustainable business development, the Chief Operating & Growth Officer secures the financial and operational health of the organization, supporting the delivery of high-value services to clients worldwide.

Francois Benard, the Team Captain at Parexel, directs the collaborative efforts of specialized project teams focused on delivering high-impact clinical research solutions. Overseeing the day-to-day coordination of cross-functional groups, the Team Captain ensures that project milestones are met with precision and efficiency. Benard manages the internal communication flow, facilitating seamless cooperation between data management, biostatistics, and clinical operations teams. The Team Captain drives the implementation of best practices within project teams, ensuring that all deliverables align with the company's quality standards. Francois Benard fosters a culture of accountability and excellence, supporting the successful execution of complex clinical trials. By providing clear direction and support to team members, the Team Captain ensures that the company consistently meets the rigorous demands of its biopharmaceutical clients, contributing to the overall success of the organization's research and development initiatives.